Drugs / autologous platelet plasma
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07020559 Comparator | Apr 2026 → Dec 2027 expected | impaired renal function disease | Peking University Third Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous platelet plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07020559 ↗ |
| Known as | Autologous platelet-rich plasma | “Autologous platelet-rich plasma from the patient themselves” NCT07020559 ↗ |